| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 14,980 | 22,705 | 26,399 | 26,217 | | Cost of Revenue | 146 | 4,325 | 5,792 | 7,644 | | | Gross Profit | 14,834 | 18,380 | 20,607 | 18,573 | | | Operating Expenses | | Research Development | 5,756 | 7,809 | 6,799 | 7,347 | | Selling General and Administrative | 6,528 | 8,955 | 8,346 | 12,002 | | Non Recurring |
-
| 959 | 548 | 4,931 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,550 | 657 | 4,914 | (5,707) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (151) | (543) | (528) | (955) | | Earnings Before Interest And Taxes | 2,399 | 114 | 4,386 | (6,662) | | Interest Expense |
-
| 600 | 346 | 483 | | Income Before Tax | 2,399 | (486) | 4,040 | (7,145) | | Income Tax Expense | 1,804 | 323 | (937) | (178) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 595 | (809) | 4,977 | (6,967) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 595 | (809) | 4,977 | (6,967) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $595 | ($809) | $4,977 | ($6,967) |
|
0.47% Nasdaq 0.00%
Income Statement
